类圆线虫感染

Boulware DR, Stauffer WM, Hendel-Paterson BR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med. 2007;120:545.e1-545.e8.

• 全文
• 摘要

Loutfy MR, Wilson M, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66:749-752.

• 全文
• 摘要

Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;(1):CD007745.

• 全文
• 摘要

Suputtamongkol Y, Premasathian N, Bhumimuang K, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis. 2011;5:e1044.

• 全文
• 摘要

1.  Walzer PD, Milder JE, Banwell JG, et al. Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg. 1982;31:313-319.

• 摘要

2.  Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis. 1989;11:755-767.

• 摘要

3.  Nutman TB, Ottesen EA, Ieng S, et al. Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis. 1987;155:309-313.

• 摘要

4.  Román-Sánchez P, Pastor-Guzmán A, Moreno-Guillén S, et al. High prevalence of Strongyloides stercoralis among farm workers on the Spanish Mediterranean coast. Analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg. 2003;69:336-340.

• 全文
• 摘要

5.  Jongwutiwes U, Waywa D, Silpasakorn S, et al. Prevalence and risk factors of acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in Thailand. Pathog Glob Health. 2014;108:137-140.

• 摘要

6.  Gill GV, Welch E, Bailey JW, et al. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM. 2004;97:789-795.

• 全文
• 摘要

7.  Boulware DR, Stauffer WM, Hendel-Paterson BR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med. 2007;120:545.e1-545.e8.

• 全文
• 摘要

8.  de Silva S, Saykao P, Kelly H, et al. Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7-20 years after resettlement in Australia. Epidemiol Infect. 2002;128:439-444.

• 摘要

9.  Franco-Paredes C, Dismukes R, Nicolls D, et al. Persistent and untreated tropical infectious diseases among Sudanese refugees in the United States. Am J Trop Med Hyg. 2007;77:633-635.

• 摘要

10.  Caruana SR, Kelly HA, Ngeow JY, et al. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Travel Med. 2006;13:233-239.

• 全文
• 摘要

11.  Loutfy MR, Wilson M, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002;66:749-752.

• 全文
• 摘要

12.  Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis. 2001;33:1040-1047.

• 摘要

13.  Sousa-Figueiredo JC, Day M, Betson M, et al. Field survey for strongyloidiasis in eastern Uganda with observations on efficacy of preventive chemotherapy and co-occurrence of soil-transmitted helminthiasis/intestinal schistosomiasis. J Helminthol. 2010;20:1-9.

• 摘要

14.  ten Hove RJ, van Esbroeck M, Vervoort T, et al. Molecular diagnostics of intestinal parasites in returning travellers. Eur J Clin Microbiol Infect Dis. 2009;28:1045-1053.

• 全文
• 摘要

15.  Checkley AM, Chiodini PL, Dockrell DH, et al; British Infection Society and Hospital for Tropical Diseases. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010;60:1-20.

• 摘要

16.  Lim S, Katz K, Krajden S, et al. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ. 2004;171:479-484.

• 全文
• 摘要

17.  Newberry AM, Williams DN, Stauffer WM, et al. Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest. 2005;128:3681-3684.

• 全文
• 摘要

18.  Jeyamani R, Joseph AJ, Chacko A. Severe and treatment resistant strongyloidiasis - indicator of HTLV-I infection. Trop Gastroenterol. 2007;28:176-177.

• 摘要

19.  Zaha O, Hirata T, Uchima N, et al. Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody. J Infect Chemother. 2004;10:348-351.

• 摘要

20.  Marcos LA, Terashima A, Dupont HL, et al. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008;102:314-318.

• 摘要

21.  Centers for Disease Control and Prevention. Guidelines for overseas presumptive treatment of strongyloidiasis, schistosomiasis, and soil-transmitted helminth infections for refugees resettling to the United States. September 2013. http://www.cdc.gov/ (last accessed 4 July 2016).

• 全文

22.  Esum M, Wanji S, Tendongfor N, et al. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin. Trans R Soc Trop Med Hyg. 2001;95:673-676.

• 摘要

23.  Ducorps M, Gardon-Wendel N, Ranque S, et al. Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin. Bull Soc Pathol Exot. 1995;88:105-112.

• 摘要

24.  Gardon J, Gardon-Wendel N, Demanga-Ngangue, et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350:18-22.

• 摘要

25.  Repetto SA, Ruybal P, Solana ME, et al. Comparison between PCR and larvae visualization methods for diagnosis of Strongyloides stercoralis out of endemic area: a proposed algorithm. Acta Trop. 2016;157:169-177.

• 摘要

26.  Salazar SA, Gutierrez C, Berk SL. Value of the agar plate method for the diagnosis of intestinal strongyloidiasis. Diagn Microbiol Infect Dis. 1995;23:141-145.

• 摘要

27.  Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis. 2006;42:363-367.

• 全文
• 摘要

28.  Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016;(1):CD007745.

• 全文
• 摘要

29.  Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, et al. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents. 2008;31:46-49.

• 摘要

30.  Marti H, Haji HJ, Savioli L, et al. A comparative trial of a single dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil transmitted helminth infections in children. Am J Trop Med Hyg. 1996;55:477-481.

• 摘要

31.  Bisoffi Z, Buonfrate D, Angheben A, et al. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl Trop Dis. 2011;5:e1254.

• 全文
• 摘要

32.  Nontasut P, Muennoo C, Sa-nguankiat S, et al. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J Trop Med Public Health. 2005;36:442-444.

• 摘要

33.  Turner SA, Maclean JD, Fleckenstein L, et al. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg. 2005;73:911-914.

• 全文
• 摘要

34.  Toma H, Sato Y, Shiroma Y, et al. Comparative studies on the efficacy of three anti-helminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health 2000;31:147-151.

• 摘要

35.  Suputtamongkol Y, Premasathian N, Bhumimuang K, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis. 2011;5:e1044.

• 全文
• 摘要

36.  Gyapong JO, Chinbuah MA, Gyapong M. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Trop Med Int Health. 2003;8:1093-1101.

• 摘要

37.  Kobayashi J, Sato Y, Toma H, et al. Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis. Diagn Microbiol Infect Dis. 1994;18:19-23.

• 摘要

38.  Swanson SJ, Phares CR, Mamo B, et al. Albendazole therapy and enteric parasites in United States–bound refugees. N Engl J Med. 2012;366:1498-1507.

• 摘要

39.  Biggs BA, Caruana S, Mihrshahi S, et al. Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg. 2009;80:788-791.

• 摘要

40.  Salvador F, Sulleiro E, Sánchez-Montalvá A, et al. Usefulness of strongyloides stercoralis serology in the management of patients with eosinophilia. Am J Trop Med Hyg. 2014;90:830-834.

• 全文
• 摘要